Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: Prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe

Journal of Nuclear Medicine

Volumn 48, Issue 5, 2007, Pages 776-782

  Lin, Tina W ^a   Kung De Aburto, Michelle A ^a   Dahlbom, Magnus ^a   Huang, Lynn L ^a   Marvi, Michael M ^a   Tang, Michael ^a   Czernin, Johannes ^a   Phelps, Michael E ^a   Silverman, Daniel H S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

18F FDG; Metabolic asymmetry; PET; Presurgical evaluation; Quantitative assessment; Seizure free status; Temporal lobe epilepsy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAIN ASYMMETRY; BRAIN SCINTISCANNING; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; TEMPORAL LOBE EPILEPSY; ALGORITHM; BRAIN; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; METABOLISM; METHODOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADULT; ALGORITHMS; BRAIN; EPILEPSY, TEMPORAL LOBE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 34250680647     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.106.034249     Document Type: Article

References (37)

1. Newberg AB, Alavi A. PET in seizure disorders. Radiol Clin North Am. 2005;43:79-92.
2. Engel J Jr. Surgery for seizures. N Engl J Med. 1996;334:647-652.
3. Hauser WA. The natural history of drug resistant epilepsy: epidemiologic considerations. Epilepsy Res Suppl. 1992;5:25-28.
4. Shorvon S. Medical services for epilepsy. In: Richens A, Laidlaw, J, Oxley, J, eds. A Textbook of Epilepsy. 3rd ed. London, U.K.: Churchill Livingstone; 1988:611-630.
5. Ward AA Jr. Perspectives for surgical therapy of epilepsy. Res Publ Assoc Res Nerv Ment Dis. 1983;61:371-390.
6. Pillay PK, Lim SH, Chee M, Awad I, Luders H. Epilepsy surgery in children and adults. Ann Acad Med Singapore. 1993;22:501-512.
7. Engel J, Cascino GD, Shields WD. Surgically remedial syndromes. In: Engel J, Pedley, TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia, PA: Lippincot-Raven; 1997:1687-1696.
8. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311-318.
9. Engel J Jr. Clinical neurophysiology, neuroimaging, and the surgical treatment of epilepsy. Curr Opin Neurol Neurosurg. 1993;6:240-249.
10. Mathern GW, Giza CC, Yudovin S, et al. Postoperative seizure control and antiepileptic drug use in pediatric epilepsy surgery patients: the UCLA experience, 1986-1997. Epilepsia. 1999;40:1740-1749.
11. Engel J Jr, Van Ness PC, Rasmussen TB, et al. Outcome with respect to epileptic seizures. In: Engel J Jr., ed. Surgical Treatment of the Epilepsies. 2nd ed. New York, NY: Raven Press; 1993:609-622.
12. Rowe CC. Nuclear medicine in the management of a patient with epilepsy. In: Ell PJ, Gambhir, SS, eds. Nuclear Medicine in Clinical Diagnosis and Treatment. 3rd ed. London, U.K.: Churchill Livingstone; 2004:1371-1385.
13. Labiner DM, Weinand ME, Brainerd CJ, Ahern GL, Herring AM, Melgar MA. Prognostic value of concordant seizure focus localizing data in the selection of temporal lobectomy candidates. Neurol Res. 2002;24:747-755.
14. Cummings TJ, Chugani DC, Chugani HT. Positron emission tomography in pediatric epilepsy. Neurosurg Clin N Am. 1995;6:465-472.
15. Wyllie E. Surgery for catastrophic localization-related epilepsy in infants. Epilepsia. 1996;37:S22-S25.
16. Laxer KD, Garcia PA. Imaging criteria to identify the epileptic focus: magnetic resonance imaging, magnetic resonance spectroscopy, positron emission tomography scanning, and single photon emission computed tomography. Neurosurg Clin N Am. 1993;4:199-209.
17. Spencer SS. The relative contributions of MRI, SPECT, and PET imaging in epilepsy. Epilepsia. 1994;35:S72-S89.
18. Sperling MR. Neuroimaging in epilepsy: recent developments in MR imaging, positron-emission tomography, and single-photon emission tomography. Neurol Clin. 1993;11:883-903.
19. Xiong J, Nickerson LD, Downs JH 3rd, Fox PT. Basic principles and neurosurgical applications of positron emission tomography. Neurosurg Clin N Am. 1997;8:293-306.
20. Casse R, Rowe CC, Newton M, Berlangieri SU, Scott AM. Positron emission tomography and epilepsy. Mol Imaging Biol. 2002;4:338-351.
21. Manno EM, Sperling MR, Ding X, et al. Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Neurology. 1994;44:2331-2336.
22. Theodore WH, Sato S, Kufta CV, Gaillard WD, Kelley K. FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Epilepsia. 1997;38:81-86.
23. 18F-FDG PET using SPM. J Nucl Med. 2003;44:1006-1012.
24. 99mTc]-HMPAO SPECT. Epilepsia. 2001;42:1515-1522.
25. 99mTc-HMPAO SPET in pediatric temporal lobe epilepsy: quantitative analysis by statistical parametric mapping, statistical probabilistic anatomical map, and subtraction ictal SPET. Seizure. 2005;14:213-220.
26. 18F-FDG-PET in frontal lobe epilepsy. Nuklearmedizin. 2003;42:190-196.
27. Wong CY, Geller EB, Chen EQ, et al. Outcome of temporal lobe epilepsy surgery predicted by statistical parametric PET imaging. J Nucl Med. 1996;37:1094-1100.
28. Hikima A, Mochizuki H, Oriuchi N, Endo K, Morikawa A. Semiquantitative analysis of interictal glucose metabolism between generalized epilepsy and localization related epilepsy. Ann Nucl Med. 2004;18:579-584.
29. Muzik O, Pourabdollah S, Juhasz C, Chugani DC, Janisse J, Draghici S. Application of an objective method for localizing bilateral cortical FDG PET abnormalities to guide the resection of epileptic foci. IEEE Trans Biomed Eng. 2005;52:1574-1581.
30. Csaba J. Positron emission tomography in presurgical localization of epileptic foci. Ideggyogy Sz. 2003;56:249-254.
31. 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? J Neurol Neurosurg Psychiatry. 1997;62:141-150.
32. Goethals I, Van de Wiele C, Boon P, Dierckx R. Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies? Eur J Nucl Med Mol Imaging. 2003;30:325-328.
33. 11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain. 2002;125:2257-2271.
34. 11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Neurology. 1999;53:2037-2045.
35. 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy. Neurol India. 2004;52:457-462.
36. 99mTc-HMPAO SPECT in temporal lobe epilepsy: relation to clinical variables. Epilepsia. 2001;42:869-874.
37. Lee SK, Lee SY, Kim KK, Hong KS, Lee DS, Chung CK. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol. 2005;58: 525-532.